[Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch
M
M
Klinik für Endokrinologie, Diabetologie und Suchtmedizin, Klinikum Schwabing, München. Martin.Fuechtenbusch@gmx.de
Hummel
M
M
D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D002423:Cause of Death; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D003925:Diabetic Angiopathies / Q000097:blood / Q000401:mortality / Q000517:prevention & control; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents